In addition to radiotherapy, the c-MET tyrosine kinase inhibitor PF-2341066 enhanced the effect of cisplatin in HNSCC.327 Not all c-MET inhibitors in combination with other regimens had a synergistic effect. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.